109 results
Page 3 of 6
424B3
esirvh r3m
16 Nov 22
Prospectus supplement
4:26pm
S-3
q1ln 8qr733axkkna64
4 Nov 22
Shelf registration
4:47pm
8-K
EX-99.1
dxjmf1cf vdsc7
3 Nov 22
Annexon Reports Third Quarter 2022 Financial Results and Plans to Provide Updates on Complement Therapeutic Portfolio in January 2023
6:45am
8-K
EX-99.1
1hzagznae m1ttwqv798
8 Aug 22
Annexon Biosciences Highlights Business and Portfolio Progress and Key Anticipated Milestones and Reports Second Quarter 2022 Financial Results
4:30pm
8-K
EX-10.1
mjh79gs67iai56e80e0
8 Jul 22
Annexon Announces $130 Million Private Placement Financing
5:19pm
8-K
EX-99.1
non6yvsiriea2b83
7 Jun 22
Other Events
4:06pm
8-K
EX-99.1
1ey2yi89cik8tg3ur4
9 May 22
Annexon Biosciences Highlights Portfolio Progress and Key Anticipated Milestones, and Reports First Quarter 2022 Financial Results
4:20pm
POS AM
mfn9144 xx2eqv60a00d
1 Mar 22
Prospectus update (post-effective amendment)
6:38pm
POSASR
d7fn3
1 Mar 22
Automatic shelf registration (post-effective amendment)
4:01pm
8-K
EX-99.1
hoeye5k
4 Jan 22
ANX005 Has Been Generally Well-Tolerated and Has Shown Full Target Engagement of C1q in the CSF
4:16pm
8-K
EX-99.1
d9nymtmf c5
9 Nov 21
Annexon Biosciences Announces Business and Program Highlights and Reports Third Quarter 2021 Financial Results
4:16pm